Premium
Synthesis, In Vitro Biological Evaluation, and Molecular Docking of New Triazoles as Potent Antifungal Agents
Author(s) -
Li Xiang,
Liu Chao,
Tang Sheng,
Wu Qiuye,
Hu Honggang,
Zhao Qingjie,
Zou Yan
Publication year - 2016
Publication title -
archiv der pharmazie
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.468
H-Index - 61
eISSN - 1521-4184
pISSN - 0365-6233
DOI - 10.1002/ardp.201500313
Subject(s) - in vitro , docking (animal) , chemistry , antifungal , cycloaddition , triazole , stereochemistry , azole , combinatorial chemistry , biological activity , broad spectrum , active site , click chemistry , biochemistry , organic chemistry , enzyme , biology , catalysis , microbiology and biotechnology , medicine , nursing
Based on the structure of the active site of CYP51 and the structure–activity relationships of azole antifungal compounds that we designed in a previous study, a series of 1‐{1‐[2‐(substitutedbenzyloxy)ethyl]‐1 H ‐1,2,3‐triazol‐4‐yl}‐2‐(2,4‐difluorophenyl)‐3‐(1 H ‐1,2,4‐triazol‐1‐yl)propan‐2‐ols ( 6a – n ) were designed and synthesized utilizing copper‐catalyzed azide‐alkyne cycloaddition. Preliminary antifungal tests against eight human pathogenic fungi in vitro showed that all the title compounds exhibited excellent antifungal activities with a broad spectrum in vitro . Molecular docking results indicated that the interaction between the title compounds and CYP51 comprised π–π interactions, hydrophobic interactions, and the narrow hydrophobic cleft.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom